Stocktoria
Mineralys Therapeutics, Inc. MLYS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-02-10
Mineralys Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 1,911,433 | $51.8M |
| D. E. Shaw & Co., Inc. | 887,192 | $24.0M |
| BlackRock Finance, Inc. | 2,045,702 | $23.9M |
| CITADEL ADVISORS LLC | 763,141 | $20.7M |
| MILLENNIUM MANAGEMENT LLC | 525,260 | $14.2M |
| RENAISSANCE TECHNOLOGIES LLC | 382,800 | $10.4M |
| TWO SIGMA INVESTMENTS, LP | 311,488 | $8.4M |
| AQR CAPITAL MANAGEMENT LLC | 149,086 | $4.0M |
Source: SEC EDGAR filings · CIK 0001933414 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.